Wave Life Sciences Ltd. (WVE) Stock: A Strong Pick In The Biotech Industry?


Wave Life Sciences Ltd. (WVE) is gaining in the market today. The company, one that is focused on the biotechnology sector, is presently priced at $26.01 after heading up 6.29% so far today. In terms of biotechnology stocks, there are quite a few aspects that have the potential to generate movement in the market. News is one of the most common reasons for movement. Here are the recent stories surrounding WVE:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-17-19 11:10AM Wave Life Sciences Plunges After DMD Study Data Readout
07:48AM The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO
Apr-16-19 05:17PM Qualcomm and Progressive jump while Wave Life Sciences drops
12:14PM Why Wave Life Sciences’s Valuation Is Falling By 25%
07:00AM Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design

Nonetheless, any time investors are making an investing decision, prospective investors should take a look at much more than news, especially in the highly speculative biotechnology sector. Here’s what’s going on with Wave Life Sciences Ltd..

Recent Moves From WVE

Although a move up on a single session, like the gain that we’re seeing from Wave Life Sciences Ltd. may make some investors happy, a single session move by itself shouldn’t be the basis of a decision to, or not to, invest in a stock. It’s always important to look into trends beyond a single session. As it relates to WVE, below are the movements that we have seen:

  • Past 5 Sessions – In the last seven days, WVE has produced a change in price amounting to -23.30%.
  • Monthly – The ROI from Wave Life Sciences Ltd. in the past month works out to -43.53%.
  • Quarterly – In the past three months, the company has generated a return that works out to -40.89%
  • Past 6 Months – Throughout the last 6 months, investors have seen a change that equates to -44.42% from the company.
  • This Year So Far – Since the open of this year WVE has produced a ROI of -38.13%.
  • Annually – Finally, in the past full year, we have seen movement of -38.15% out of WVE. Over this period, the stock has sold at a high of -53.55% and a low price of 13.58%.

Key Ratios

Looking at various key ratios having to do with a stock can provide investors a view of just how risky and/or rewarding a pick might be. Here are a few of the important ratios to look at when looking at WVE.

Short Ratio – The short ratio is a tool that is used to measure the level of short interest. The higher this ratio, the more investors are expecting that the price of the stock is going to tumble. Throughout the sector, biotech stocks can have a higher short ratio. On the other hand, we also tend to see quite a few short squeezes in the space. Nonetheless, as it relates to Wave Life Sciences Ltd., the stock’s short ratio clocks in at 6.09.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Basically, they measure If a company is able to cover its debts when they mature based on current assets or quick assets. In the biotech sector, companies are reliant on the continuation of investor support, the quick and current ratios can seem bad. However, several better companies in the biotechnology sector come with good quick and current ratios. As it relates to WVE, the quick and current ratios add up to 1.60 and 1.60 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets currently owned by the company to the price of shares. In this case, the book to share value ratio comes in at 2.49.

Cash To Share Value – Finally, the cash to share value ratio compares the total cash on hand to the value of shares. Several clinical stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech sector, this is an important ratio to look into. In the case of WVE, the cash to share value comes to 5.41.

How Analysts Feel About Wave Life Sciences Ltd.

Although it’s never a good idea to unknowingly follow the opinions of analysts, it is a smart idea to use their thoughts when validating your own due diligence when it comes to making investment decisions in the biotechnology sector. Here are the most recent moves that we have seen from analysts as it relates to WVE.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-17-19 Reiterated H.C. Wainwright Buy $49 → $33
Aug-07-18 Initiated Stifel Buy $56
Jul-23-18 Initiated H.C. Wainwright Buy $49
Mar-19-18 Reiterated Mizuho Buy $34 → $65
Feb-15-17 Initiated H.C. Wainwright Buy $41

Moves From Big Money Players

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in WVE, here’s what we’re seeing:

  • Institutional Investors – Currently, institutions hold 73.40% of Wave Life Sciences Ltd.. On the other hand, it’s worth considering that institutional ownership has changed in the amount of 1.14% over the past quarter.
  • Investors On The Inside – When it comes to insiders, those close to the situation currently hold 1.60% of Wave Life Sciences Ltd.. Their ownership of the company has seen a change of 0 throughout the past 3 months.

A Look At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 32.31M shares of Wave Life Sciences Ltd. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, WVE has a float of 26.36M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to WVE, the short percent of the float is 12.11%.


At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-5.19. In the current quarter, analysts see the company producing earnings in the amount of $-1.13. Over the last 5 years, WVE has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of -16.10% and revenue has seen movement of 227.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings actually play an important part in my ability to learn. Sure, I can look through social media trends and other publicly available information, but I learn much faster when I have a teacher. If you’d like to teach me something, I would love to learn! Is there other data that you’re interested in? Am I saying something wrong? Is there another way to look at something? If so, leave a comment below and I will use it to serve you better!


Please enter your comment!
Please enter your name here